retrovir (azt) solution
viiv healthcare ulc - zidovudine - solution - 10mg - zidovudine 10mg - nucleoside and nucleotide reverse transcriptase inhibitors
retrovir (azt) syrup
viiv healthcare ulc - zidovudine - syrup - 50mg - zidovudine 50mg - nucleoside and nucleotide reverse transcriptase inhibitors
zalmoxis
molmed spa - allogeneic t cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (Δlngfr) and the herpes simplex i virus thymidine kinase (hsv-tk mut2) - hematopoietic stem cell transplantation; graft vs host disease - antineoplastic agents - zalmoxis is indicated as adjunctive treatment in haploidentical haematopoietic stem cell transplantation (hsct) of adult patients with high-risk haematological malignancies.
strimvelis
fondazione telethon ets - autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with retroviral vector that encodes for the human adenosine deaminase (ada) cdna sequence from human haematopoietic stem/progenitor (cd34+) cells - severe combined immunodeficiency - immunostimulants, - strimvelis is indicated for the treatment of patients with severe combined immunodeficiency due to adenosine deaminase deficiency (ada-scid), for whom no suitable human leukocyte antigen (hla)-matched related stem cell donor is available (see section 4.2 and section 4.4).
retrovir (azt) capsule
viiv healthcare ulc - zidovudine - capsule - 100mg - zidovudine 100mg - nucleoside and nucleotide reverse transcriptase inhibitors
retrovir 50 mg/5 ml solución 200 ml
retrovir 250 mg 40 càpsules
retrovir tablets 300 milligram
viiv healthcare uk ltd - zidovudine - tablets - 300 milligram
retrovir 300 milligram tablets
viiv healthcare uk ltd - zidovudine - tablets - 300 milligram
retrovir capsule 250 mg
glaxosmithkline pte ltd - zidovudine - capsule - 250 mg